Enzyme‐responsive and biocompatible supramolecular nanocarriers (NCs) have attracted intensive attention in the field of biomaterials, and have found many feasible applications, particularly for controlling drug‐release at specific anchor sites where the enzyme is overexpressed. However, the introduction of specific enzyme‐responsive sites in drug nanocarriers that can be enzymatically triggered to release drugs within tumor cells remains a challenge. In this manuscript, an enzyme‐responsive supramolecular nanoparticle, (SBE)7m‐β‐CD ⊃ PS NPs is successfully prepared, based on inducing aggregation of negatively charged cyclodextrin toward positively charged protein. The obtained nanoparticles showed trypsin‐trigger disassemble behavior that is considered as drug vehicles to load antitumor drug celastrol (CSL). Furthermore, CSL‐loaded NPs exhibit controlled release behavior of CSL in response to trypsin (TPS) stimulation. Notably, cell biology experiments reveal that loading CSL by (SBE)7m‐β‐CD ⊃ PS NPs not only reduces cytotoxicity for normal cells but also presents a similar therapeutic effect of free CSL for five tumor cells. The obtained nanoparticle appears to hold practical potential for the controllable release of CSL in tumor cells.
Hydroxycamptothecin (HCPT) is a first-line anti-colorectal cancer chemotherapeutic agent. Nevertheless, the poor tumor-specific delivery properties of HCPT make it indiscriminate in killing normal and cancer cells, as well as impossible to achieve sustained treatment due to its low cumulative concentration in cancer cells. Here, a pH and temperature co-responsive supramolecular nanocarrier anchoring with folic acid (FA) ligands, termed PEHA-β-CD-FA/SDS NPs, was prepared based on electrostatic interaction between cationic mono-(6-pentaethylenehexamine)-β-CD (PEHA-β-CD-FA) and anionic sodium dodecyl sulfate (SDS). PEHA-β-CD-FA/SDS NPs exhibited assembly/disassembly behavior accompanied by co-regulation of temperature and pH and are therefore employed as nanocarriers to load, deliver, and release HCPT. Notably, the release rate of HCPT achieved 93.6% at pH = 8.5 and T = 45 C which simulates the microenvironment of colon cancer cells. Cell biology experiments demonstrated that the more precise targeting ability of HCPT-loaded NPs resulted in higher cytotoxicity to tumor cells but also less toxicity to normal cells BEAS-2B. Flow cytometry apoptosis analysis also demonstrated that HCPT-loaded NPs had a significant growth-inhibitory effect on SW480 colon cancer cells. We expected that the supramolecular nanoparticles combining active and passive targeting capabilities could be further developed as potential drug carrier formulations for enhancing the clinical efficacy of anti-colon cancer drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.